For the Inventor, By the Inventor

Enter assignee name

Yamanouchi Pharmaceutical Company Ltd.

USPTO Granted Patents = 329

Trademarks = 8

Forward Citations = 4,962

Loading Chart...

Loading Chart...

533 inventors (with patents filed for the assignee):

Masuo Murakami (35 out of 35 patents)

Yasuo Isomura (29 out of 29 patents)

Takashi Fujikura (28 out of 29 patents)

4. Isao Yanagisawa (24 out of 24 patents)

5. Noriki Ito (22 out of 22 patents)

6. Kunihiro Niigata (21 out of 21 patents)

7. Toichi Takenaka (21 out of 21 patents)

8. Toshiyasu Mase (20 out of 23 patents)

9. Kiyoshi Murase (18 out of 33 patents)

10. Akihiro Tanaka (17 out of 118 patents)

11. Shuichi Sakamoto (17 out of 24 patents)

12. Kenichi Tomioka (17 out of 20 patents)

13. Hiroitsu Kawata (17 out of 17 patents)

14. Masayoshi Aruga (16 out of 16 patents)

15. Toshinari Tamura (15 out of 15 patents)

Core Competencies:

Melanocortin Receptor Agonists

Stable Oral Solid Drug Composition

Pharmaceutical Composition

Sustained Release Pharmaceutical Compositions

Peptide Leukotriene Receptor

Hydrogel-Forming Sustained-Release Preparation

Colon-Specific Drug Release System

Medicinal Compositions for Neurogenic Pain

Naphthyridine Derivatives

Quick Disintegrating Tablets

Fused Heteroaryl Derivatives

Amide Derivatives

329 patents: Sort by Forward Citations

1. 7989634 - Melanocortin receptor agonists (2011-08-02),

2. 7794748 - Stable oral solid drug composition (2010-09-14),

3. 7268150 - 2-cyano-4-fluoropyrrolidine derivative or its salt (2007-09-11),

4. 7008640 - Pharmaceutical composition for oral use with improved absorption (2006-03-07),

5. 6960591 - Propane-1,3-dione derivative (2005-11-01),

6. 6949543 - Amide derivative (2005-09-27),

7. 6927233 - 5ht2 agonists for controlling IOP and treating glaucoma (2005-08-09),

8. 6919372 - Sustained release pharmaceutical compositions (2005-07-19),

9. 6903125 - Tetrahydro-2H-thiopyran-4-carboxamide derivative (2005-06-07),

10. 6899899 - Rapidly disintegrable pharmaceutical composition (2005-05-31),

11. 6878525 - Peptide leukotriene receptor (2005-04-12),

12. 6877598 - Apparatus and method for transferring formed pieces (2005-04-12),

13. 6872405 - Quick-disintegrating tablet in buccal cavity and manufacturing method thereof (2005-03-29),

14. 6861070 - Medicinal compositions for treating evacuatory insufficiency (2005-03-01),

15. 6838457 - Fused heteroaryl derivatives (2005-01-04),

Yamanouchi Pharmaceutical Company Ltd. is a renowned global pharmaceutical company based in Tokyo, Japan. With a rich history spanning over a century, Yamanouchi focuses on the research, development, manufacturing, and distribution of innovative drugs and healthcare solutions. The company's commitment to improving human health and enhancing the quality of life has propelled them to become a leader in the pharmaceutical industry. Visit their website to learn more about Yamanouchi's diverse portfolio of prescription drugs, OTC products, and medical devices.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

329 Patents

#224 in Tokyo

#487 in Japan

#2,664 in the World

Yamanouchi Pharmaceutical Company Ltd.

Forward Citations = 4,962

533 inventors:

Masuo Murakami (35 out of 35 patents)

Yasuo Isomura (29 out of 29 patents)

Takashi Fujikura (28 out of 29 patents)

4. Isao Yanagisawa (24 out of 24 patents)

5. Noriki Ito (22 out of 22 patents)

Please report any incorrect information to support@idiyas.com

Loading…